Early antibody treatment, inflammation, and risk of post-COVID conditions is a research paper published in mBio (2023). On theSindex it has a DataRank of 0. It has been cited 22 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. Department of Defense
Grant: W911QY2090012
HHS | NIH | National Institute of Allergy and Infectious Diseases
Grant: R01AI152078
HHS | NIH | National Institute on Drug Abuse
Grant: F31DA054849
HHS | NIH | National Center for Advancing Translational Sciences
Grant: U24TR001609
HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01DK131926
HHS | NIH | National Institute of Allergy and Infectious Diseases
Grant: R01AI120938S1
NCATS NIH HHS
Grant: UL1 TR001409
NIAID NIH HHS
Grant: R01 AI120938
National Institutes of Health
Grant: 5U24TR001609-06
Johns Hopkins-Tufts Trial Innovation Center
National Institutes of Health
Grant: 5F31DA054849-03
Colliding Epidemics During an Opioid Crisis: Impact of the COVID-19 Pandemic on Determinants of HIV and HCV Transmission Among People Who Inject Drugs
National Institutes of Health
Grant: 5R01DK131926-04
T-cell depletion and maintenance of the HIV-1 latent reservoir in distinct tissue compartments
National Institutes of Health
Grant: 3R01AI152078-01S1
Conjugate vaccines for prevention and treatment of cryptococcosis - COVID-19 Revision Supplement
National Institutes of Health
Grant: 3R01AI120938-05S1
Unlocking the Potential of HIV-Infected Deceased Donors for Organ Transplantation
HHS | NIH | National Institute of Allergy and Infectious Diseases Division of Intramural Research
FWCI
3.46
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals